Myriad Genetics partners with AWS to enhance Image Genius, speeding up document processing, and improving insurance workflows ...

Every person's DNA tells a unique story. To unlock the full potential of genetic research, scientists need tools that reflect ...

The way to make a plant grow more may be to take something away. Trimming a section off a plant gene raised rice harvests by ...

Deep learning approaches have transformed how scientists predict the activity and function of DNA sequences in the genome. A ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including Myriad Genetics (NASDAQ:MYGN) and its peers.

Researchers have identified the first evidence of genetic risk factors associated with borderline personality disorder (BPD).

How much do your genes and upbringing determine your success? A landmark Norwegian study untangles the complex interplay between genetics, family, and social policies in shaping who thrives. Study: ...

SOPHiA GENETICS President and CEO Ross Muken discusses the use of AI and technology in diagnosing and treating patients, ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces the full commercial launch of ...

Geviti introduces clinical-grade genetics and Makor AI, combining DNA, biomarkers, and AI into personalized preventative care.

Health Secretary Robert F. Kennedy Jr. continues to falsely claim that vaccines cause autism despite overwhelming research to the contrary. Scientists say autism is primarily genetic, pointing to twin ...

View SOPHiA GENETICS SA SOPH stock quote prices, financial information, real-time forecasts, and company news from CNN.